Closing Bell: Searching For Direction, Bank Earnings Preview & Cancer Vaccine Partnership 10/12/22
Stocks struggling to find direction after the Federal Reserve's last meeting minutes showed the central bank will keep hiking rates until inflation begins to cool. But there was some optimism that the Fed could slow its tightening if financial market turbulence continues. Allianz Chief Economic Advisor Mohamed El-Erian discusses whether the Fed will be able to manage a soft landing and what he expects from Thursday's key consumer inflation report. Morgan Stanley's Betsy Graseck explains why bank investors should strap in for a rocky ride this earnings season and reveals which bank should stand out from its peers. And Jefferies' Michael Yee on what Moderna's partnerships to jointly develop a skin cancer vaccine with Merck means for those stocks.
October 12, 2022
42 min
Full
297 of 2,295
October 12, 2022
Closing Bell: Searching For Direction, Bank Earnings Preview & Cancer Vaccine Partnership 10/12/22
0:00 / 42:59
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Cnbc Episodes Around October 12, 2022
Episode 297 of 2,295 — walk the feed in the order it was published.
49:40Closing Bell: Rally gains steam, Musk makes a deal, Hasbro CEO’s growth plan 10/4/22
42:59This episodeClosing Bell: Searching For Direction, Bank Earnings Preview & Cancer Vaccine Partnership 10/12/22
Summary
Stocks struggling to find direction after the Federal Reserve's last meeting minutes showed the central bank will keep hiking rates until inflation begins to cool. But there was some optimism that the Fed could slow its tightening if financial market turbulence continues. Allianz Chief Economic Advisor Mohamed El-Erian discusses whether the Fed will be able to manage a soft landing and what he expects from Thursday's key consumer inflation report. Morgan Stanley's Betsy Graseck explains why bank investors should strap in for a rocky ride this earnings season and reveals which bank should stand out from its peers. And Jefferies' Michael Yee on what Moderna's partnerships to jointly develop a skin cancer vaccine with Merck means for those stocks. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.